Scholarlink

Background <p>Axial spondyloarthritis (axSpA) is chronic autoimmune disease affecting axial skeleton. Recently autoantibodies against CD74 have been linked to the pathogenesis of axSpA.</p> Objectives <p>Investigate the diagnostic value of anti-CD74 in Egyptian axSpA patients and their relation to disease activity.</p> Methods <p>This study included 30 axSpA patients and control groups, which included 30 patients with peripheral psoriatic arthritis, and 30 healthy volunteers. disease activity was assessed using ASDAS-CRP (Ankylosing Spondylitis Disease Activity Score) and BASDAI (bath ankylosing spondylitis disease activity index) for axSpA patients. Bath ankylosing spondylitis functional index (BASFI) was used for functional assessment and mobility was assessed using Bath Ankylosing Spondylitis Metrology Index (BASMI). ESR, CRP and serum anti-CD74 IgA were evaluated.</p> Results <p>There was no significant difference between the three studied groups regarding sex, age, and BMI. The serum levels of anti-CD74 IgA antibodies were significantly higher in axSpA patients compared to control groups.73.3, 66.6 and 3.3% of the axSpA, Peripheral psoriatic arthritis and healthy group, respectively, were anti- CD74 IgA antibody positive. Its specificity was 96.67% compared to the healthy control group, and 33.3% specificity compared to the peripheral psoriatic arthritis group. There was no significant correlation between anti-CD74 IgA antibodies and age, sex, duration of the disease, acute phase reactant, ASDAS-CRP, BASDAI, BASFI, and BASMI.</p> Conclusions <p>IgA anti-CD74 may be a useful marker for identifying axSpA. Further research on patients with peripheral SpA is required to determine the practical benefits of this biomarker.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Anti-CD74 IgA as a potential biomarker in axial spondyloarthritis: diagnostic utility and clinical implications

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月4日

查看全文
  • Gehad Elsayed Mohammed Ammar,
  • Ali Eed Eldeeb,
  • Heba Ahmed Mourad,
  • Samar AbdAlhamed Tabra

摘要

Background

Axial spondyloarthritis (axSpA) is chronic autoimmune disease affecting axial skeleton. Recently autoantibodies against CD74 have been linked to the pathogenesis of axSpA.

Objectives

Investigate the diagnostic value of anti-CD74 in Egyptian axSpA patients and their relation to disease activity.

Methods

This study included 30 axSpA patients and control groups, which included 30 patients with peripheral psoriatic arthritis, and 30 healthy volunteers. disease activity was assessed using ASDAS-CRP (Ankylosing Spondylitis Disease Activity Score) and BASDAI (bath ankylosing spondylitis disease activity index) for axSpA patients. Bath ankylosing spondylitis functional index (BASFI) was used for functional assessment and mobility was assessed using Bath Ankylosing Spondylitis Metrology Index (BASMI). ESR, CRP and serum anti-CD74 IgA were evaluated.

Results

There was no significant difference between the three studied groups regarding sex, age, and BMI. The serum levels of anti-CD74 IgA antibodies were significantly higher in axSpA patients compared to control groups.73.3, 66.6 and 3.3% of the axSpA, Peripheral psoriatic arthritis and healthy group, respectively, were anti- CD74 IgA antibody positive. Its specificity was 96.67% compared to the healthy control group, and 33.3% specificity compared to the peripheral psoriatic arthritis group. There was no significant correlation between anti-CD74 IgA antibodies and age, sex, duration of the disease, acute phase reactant, ASDAS-CRP, BASDAI, BASFI, and BASMI.

Conclusions

IgA anti-CD74 may be a useful marker for identifying axSpA. Further research on patients with peripheral SpA is required to determine the practical benefits of this biomarker.